1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow ASP7317: new trials by email Literature Review of ASP7317 trials Research Report on ASP7317
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration ASP7317, tacrolimus, trimethoprim-sulfamethoxazole - Age-Related Macular Degeneration | Phase 1 | Recruiting | Astellas Institute for Regenerative Medicine | 42 | 2018-07-13 | 2026-09-03 |
Geographic Atrophy (1) · Macular Degeneration (1)
Astellas Institute for Regenerative Medicine (1)
United States (1)